She Quit Wall Street to Start an ‘Explosive’ Company Seeing $125M a Year. It Just Launched a ‘Very Hard’-to-Achieve Product for Home Use.
AI Is Exhausting the People Who Use It Most — Here’s How to Escape the Brain Fry and Prioritize Your Peace
Should You Buy Into Pfizer (PFE) Today? Despite a slowdown of Covid-19 vaccine sales in the last reported quarter, biopharmaceutical giant Pfizer (PFE) is positioned to deliver robust growth this year and beyond, thanks to the strength… Previous Article 'The Most Hated Man in America' Where Is Pharma Bro Martin Shkreli Now? Next Article 3 Inclusive Workplace Practices For Your Remote Team